Yes, discharge him on Subutex (buprenorphine)
You should absolutely discharge this patient on Subutex (buprenorphine) for his fentanyl use disorder. Buprenorphine is highly effective for preventing overdose and maintaining treatment in the fentanyl era, and discontinuing it at discharge would significantly increase his risk of relapse, overdose, and death.
Why Continue Buprenorphine
The evidence strongly supports continuation of buprenorphine therapy:
Overdose prevention: Recent data from the fentanyl era demonstrates that buprenorphine reduces opioid overdose risk by 61% on days with an active prescription compared to days without 1. This is the most critical outcome for mortality reduction.
Treatment retention: Patients who receive buprenorphine have lower rates of patient-directed discharge (6.9% vs 15.5%) and lower readmission rates at both 30 days (11.0% vs 25.1%) and 90 days (24.1% vs 46%) compared to those who don't receive it 2.
No dose-related overdose risk: There is no evidence that higher buprenorphine doses increase overdose risk—daily doses on days with and without overdose events were similar 1. This directly contradicts concerns about higher doses being dangerous.
Discharge Planning Specifics
Dosing considerations for fentanyl users:
- Most patients with daily fentanyl use require higher than traditional doses (often 16-24 mg daily) to prevent cravings and withdrawal 3, 4
- If he's stable on his current Subutex dose in the hospital, discharge him on that same dose
- Consider that fentanyl's high potency and long tissue half-life may necessitate doses at the higher end of the therapeutic range
Critical discharge actions:
- Verify his outpatient buprenorphine prescriber and confirm follow-up appointment before discharge 5
- Notify his addiction treatment provider about the hospitalization and any medications given that might appear on urine drug screens 5
- Provide naloxone for overdose reversal
- Counsel about avoiding benzodiazepines and alcohol, as concomitant use significantly increases overdose risk 6
Common Pitfalls to Avoid
Do NOT:
- Discontinue buprenorphine at discharge without a clear transition plan—this dramatically increases overdose and relapse risk
- Assume he needs to be "opioid-free" before leaving the hospital
- Reduce his dose arbitrarily due to concerns about "too much" buprenorphine
- Delay discharge to taper him off—this is outdated thinking from the pre-fentanyl era
Critical safety warning: The FDA label emphasizes that combining buprenorphine with benzodiazepines, sedatives, or alcohol can cause serious overdose and death 6. Counsel the patient explicitly about this risk.
The Fentanyl Context
The fentanyl era has changed buprenorphine treatment significantly 7:
- Fear of precipitated withdrawal is a major barrier, but staying on buprenorphine is safer than stopping it
- Easy access to cheap fentanyl makes discontinuation particularly dangerous
- There's no longer a one-size-fits-all approach—individualized dosing based on withdrawal symptoms and cravings is essential
Bottom line: Discharging him on Subutex protects against the highest risks—overdose death and treatment dropout. The evidence unequivocally supports continuation of buprenorphine therapy for patients using fentanyl 1, 2.